The Effect of Circadian Rhytm on Postoperative Pain Undergoing Pediatric Surgery

May 17, 2022 updated by: Faruk Cicekci

How Does Circadian Rhythm Affect Postoperative Pain After Pediatric Acute Appendicit Operation?

These circadian rhythms are self-sustained, endogenous oscillations generated by circadian clocks that persist with a period of around 24 -h under constant conditions. Multiple clinical and foundational science studies report that circadian rhythm disruption can directly alter pain thresholds. Altered circadian pain rhythms manifest inconsistently in various disease states. circadian differences exist in tolerability of administration as well as in effectiveness of analgesia during surgical, obstetric, and dental procedures, with the majority of studies demonstrating highest pain sensitivity during the overnight or early morning hours. Although the relationship between pain states and circadian rhythm has been studied in various surgical procedures and chronic pain syndromes, there is little literature examining the relationship between postoperative pain and circadian rhythm in pediatric surgical procedures. Therefore, it was aimed to evaluate the relationship between postoperative pain and circadian rhythm after pediatric acute appendicitis surgery.

Study Overview

Status

Active, not recruiting

Detailed Description

This study will be conducted with the data to be obtained from the Anesthesiology Surgery Form and Pediatric Surgery Service Forms in 200 patients aged 6-18 years, after the approval of the Faculty Local Ethics Committee in the Department of Anesthesiology, Faculty of Medicine, Selcuk University. According to the time the patients were taken into the operation, Group 1; 01:01-07:00, Group 2; 07:01-13:00, Group 3; 13:01-20:00 and Group 4; 20:01-01:00, It will be divided into four groups between. The files of the patients will be examined and demographic data such as age (year), body weight (kg), height (cm), gender, ASA scores (I-III), anesthesia and surgery time, anesthesia and surgery time will be recorded. Intraoperative vital signs; systolic arterial pressure (SAP), diastolic arterial pressure (DAP), mean arterial pressure (MAP), heart rate (HR) oxygen saturation (SpO2) Endtidal CO2 and temperature before operation (control) and 5, 10, 15, 20, 25 and 30 minutes (min) and at the end of the process (end) data will also be saved. Perioperative side effects such as nausea-vomiting, hypotension, bradycardia, tremor, respiratory distress, sore throat, headache, and dizziness symptoms will be noted if they occur. The routinely applied analgesic protocol and vital signs in the postoperative pediatric surgery service, the total amount of analgesic administered, the time to first analgesia requirement and VAS scores at 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours will also be recorded. There will be no interference with the routinely applied analgesic protocol.

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Konya, Turkey, 42080
        • Selcuk University, School of Medicine
      • Konya, Turkey, 42250
        • Selcuk University, School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 16 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Pediatric patient population of both sexes aged 6-18 years

Description

Inclusion Criteria:

  • American Society of Anesthesiologists (ASA) physical condition I-II,
  • Undergoing acute appendicitis,
  • Patients aged 6-18 years

Exclusion Criteria:

  • ASA ≥ III,
  • Uncontrolled chronic, metabolic disease,
  • Opioid or analgesic use in the last 10 days,
  • Acute peritonitis or sepsis
  • History of abnormal operation or recovery from anesthesia,
  • Patients with parents who are unwilling to give informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1
Sociodemographic and clinical data of the patients who will be operated between 01:01-07:00 AM will be recorded. The total amount of antiemetic, the time of first antiemetic use, and the VAS scores at the postoperative 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours will also be recorded.
The total amount of antiemetic,the time of first antiemetic use and VAS scores at 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours postoperatively will also be recorded according to circadian rhythm
Group 2
Patients who were operated between 07:01-13:00. Sociodemographic and clinical data of the patients who will be operated between 07:00 AM- 01:00 PM will be recorded. The total amount of antiemetic, the time of first antiemetic use, and the VAS scores at the postoperative 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours will also be recorded.
The total amount of antiemetic,the time of first antiemetic use and VAS scores at 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours postoperatively will also be recorded according to circadian rhythm
Group 3
Sociodemographic and clinical data of the patients who will be operated between 01:00 - 08:00 PM will be recorded. The total amount of antiemetic, the time of first antiemetic use and the VAS scores at the postoperative 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours will also be recorded.
The total amount of antiemetic,the time of first antiemetic use and VAS scores at 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours postoperatively will also be recorded according to circadian rhythm
Group 4
Sociodemographic and clinical data of the patients who will be operated between 08:00 PM -01:00 AM will be recorded. The total amount of antiemetic,the time of first antiemetic use, and the VAS scores at the postoperative 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours will also be recorded.
The total amount of antiemetic,the time of first antiemetic use and VAS scores at 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24th hours postoperatively will also be recorded according to circadian rhythm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The postoperative VAS pain scores
Time Frame: 1st hours , postoperatively
The VAS scores at 1st will be recorded.
1st hours , postoperatively
The postoperative VAS pain scores
Time Frame: 2nd hours , postoperatively
The VAS scores at 2nd will be recorded.
2nd hours , postoperatively
The postoperative VAS pain scores
Time Frame: 3th hours , postoperatively
The VAS scores at 3th will be recorded.
3th hours , postoperatively
The postoperative VAS pain scores
Time Frame: 6th hours , postoperatively
The VAS scores at 6th will be recorded.
6th hours , postoperatively
The postoperative VAS pain scores
Time Frame: 9th hours , postoperatively
The VAS scores at 9th will be recorded.
9th hours , postoperatively
The postoperative VAS pain scores
Time Frame: 12th hours , postoperatively
The VAS scores at 12th will be recorded.
12th hours , postoperatively
The postoperative VAS pain scores
Time Frame: 15th hours , postoperatively
The VAS scores at 15th will be recorded.
15th hours , postoperatively
The postoperative VAS pain scores
Time Frame: 18th hours , postoperatively
The VAS scores at 18th will be recorded.
18th hours , postoperatively
The postoperative VAS pain scores
Time Frame: 21th hours , postoperatively
The VAS scores at 21th will be recorded.
21th hours , postoperatively
The postoperative VAS pain scores
Time Frame: 24th hours , postoperatively
The VAS scores at 24th will be recorded.
24th hours , postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The total amount of analgesic
Time Frame: 24 hours, postoperatively
The total amount of analgesic will be recorded postoperativly .
24 hours, postoperatively
the time to first analgesia requirement
Time Frame: 24 hours, postoperatively
the time to first analgesia requirement will be recorded postoperativly .
24 hours, postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Anticipated)

August 15, 2022

Study Completion (Anticipated)

December 31, 2022

Study Registration Dates

First Submitted

April 29, 2022

First Submitted That Met QC Criteria

May 17, 2022

First Posted (Actual)

May 18, 2022

Study Record Updates

Last Update Posted (Actual)

May 18, 2022

Last Update Submitted That Met QC Criteria

May 17, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • farukcicekci5

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

I do not have a plan to make individual participant data (IPD) available to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on Group 1, Group 2, Group 3, Group 4

3
Subscribe